Lucid Diagnostics LUCD
NASDAQ LUCD
$0.96 +0.00 (+0.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lucid Diagnostics (LUCD) Operating Margin Growth (3y) (2024 - 2026)

Lucid Diagnostics (LUCD) Operating Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -201.00
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 586.00
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 78.00
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 736.00
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 887.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 963.00
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 212.00
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 535.00
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 244.00
10 Lucid Diagnostics 176.64 Mn 143.24 Mn 55,000.00 643,213.00

Historic Data

Download Data
DateValue
Jun 30, 2026 643,213.00
Mar 31, 2026 227,824.00
Dec 31, 2025 1.24 Mn
Sep 30, 2025 1.79 Mn
Mar 31, 2025 498,450.00
Dec 31, 2024 271,317.00
Sep 30, 2024 225,722.00